DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 11,600
+130 (1.13%)
At close: Oct 1, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 211.31 billion as of October 1, 2026. Its market cap has decreased by -26.04% in one year.
Market Cap
211.31B
Enterprise Value
310.81B
Revenue
148.75B
Ranking
n/a
PE Ratio
46.23
Stock Price
11,600.00
ChartMarket Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 211.31B, an increase of 1,248.63%. That is a compound annual growth rate of 12.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 211.31B | -30.79% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 308.03B |
| HEM Pharma | 238.26B |
| CellBion | 190.87B |
| NOVAREX | 177.70B |
| Vivozon Pharmaceutical | 167.56B |
| GC WellBeing | 166.45B |
| Cosmax Nbt | 149.43B |
| Kyung Dong Pharmaceutical | 147.09B |